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S U M M A R Y
Objectives: Having effective ways to cope helps HIV-infected individuals maintain good psychological
and physical well-being. This study investigated the relationship between coping self-efﬁcacy levels, as
determined by the Coping Self-Efﬁcacy Scale (CSE), HIV status disclosure, and depression in a Danish
cohort.
Methods: In 2008, the CSE was administered to 304 HIV-infected individuals to measure their conﬁdence
in their ability to cope with HIV infection. HIV status disclosure was assessed on a three-point scale:
living openly with the disease, partly openly, or secretly. The Beck Depression Inventory (BDI) was used
to assess depression prevalence and severity.
Results: The CSE score was signiﬁcantly related to depression (Spearman’s rho = 0.71; the test of H0:
BDI and coping, probability > t = 0.0001). There was a signiﬁcant relationship between higher CSE scores
and living openly with HIV. The risk of depression was four times higher in HIV-infected individuals who
did not disclose their HIV status (i.e. who lived ‘secretly’; odds ratio = 4.1) than in individuals who lived
openly.
Conclusion: Those with low CSE scores were more likely to report living secretly with HIV and to be
depressed. Disclosing HIV may constitute a social stressor, and a lack of coping self-efﬁcacy may increase
the likelihood of non-disclosure and depression. Interventions that enhance self-efﬁcacy may help in
managing the demands of daily life with HIV, increase disclosure, and reduce depression.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id
Open access under CC BY-NC-ND license.1. Introduction
HIV has become a chronic disease due to treatments that
prolong life and allow a higher quality of life for many people
infected with HIV. Nonetheless, HIV remains a stressful and
demanding condition. Psychiatric disorders are common
among those infected with HIV, and depression is especially       
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http://dx.doi.org/10.1016/j.ijid.2013.12.008prevalent.1,2 A diagnosis of HIV infection is typically a traumatic
event,3 and depression compounds the physical and emotional
stress associated with HIV infection. Depression is associated
with poor adherence to highly active antiretroviral treatment
(HAART),4–6 deterioration in psychosocial functioning, reduced
immune response, more rapid progression of HIV, and higher
mortality rates.7–13 Studies have also found that depression is
associated with unsafe sex and thus with an increased risk of
transmitting  or contracting HIV.14,15 With improved treatments
for HIV, more HIV-infected people are surviving longer and
having to cope with HIV-related stress, such as disclosure of their
HIV-positive status.
Disclosure is a recurring challenge,16 and disclosing one’s HIV
status is both an acute and recurring stressor. Disclosure can be
viewed both as impacting stress and as part of coping with HIV.ociety for Infectious Diseases. Open access under CC BY-NC-ND license.
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may be sources of stress for some, while sharing one’s positive
status may be a coping mechanism for others.
A previous qualitative study investigated Danish individuals
infected with HIV with a focus on HIV-related stressors.17 The
study revealed that each HIV-infected individual had to ﬁnd the
right balance in terms of disclosure that best suited his or her
current personal situation. Three disclosure strategies were
identiﬁed: (1) living openly (being open about their HIV status,
disclosing their status to others), (2) living partly openly
(disclosing their status to more than two people), and (3) living
secretly (being closed about their status, disclosing to two people
or fewer). Disclosure was an ongoing issue rather than just an issue
at the time of diagnosis, and there were turning points or
transitions that occurred over the years.17
Decisions surrounding disclosure may themselves constitute a
form of chronic stress that can have adverse health consequences.
Experiencing stressful life events can activate and alter the
hypothalamic–pituitary–adrenal axis, resulting in suppression of
the immune system.18 Additionally, physical and psychosocial
stress can lead to negative health behaviors such as substance use,
overeating, and non-adherence to medical care.1,18 Stress can be
thought of as resulting from an ‘‘imbalance between demands and
resources’’, or as occurring when ‘‘pressure exceeds one’s
perceived ability to cope.’’19
Coping has been the focus of research in the social sciences for a
long time and is considered a complex multidimensional process
that is sensitive to the environment (i.e., to environmental demands
and resources) and to personality dispositions that inﬂuence the
appraisal of stress and coping resources.19 When people achieve a
good ‘ﬁt’ between stressful events and their coping strategies, they
experience fewer psychological symptoms than when there is a lack
of ﬁt. Speciﬁcally, beliefs of personal efﬁcacy determine the
acquisition of knowledge on which skills are founded20 and also
determine the likelihood that knowledge and skills will be translated
into adaptive behaviors. Coping is considered one of the core
concepts in health psychology and is strongly associated with the
regulation of emotions in response to social and environmental
stressors. Coping self-efﬁcacy is rooted in the concept that people
need to believe that they can perform a coping behavior in order to
effectively engage in adaptive coping behaviors.21 Those who are
high in coping self-efﬁcacy should be better able to engage in
adaptive coping behaviors; thus, over time, they may be less
vulnerable to stress and better equipped to apply coping skills when
difﬁculties arise. In particular, they would be less likely to resort to
maladaptive coping behaviors (i.e., coping that fails to regulate
distress or manage the underlying problem), such as cognitive
escape and avoidance behaviors (including the use of alcohol or
drugs, or avoiding addressing problems).22–25 The purpose of this
study was to investigate the relationship between levels of coping
self-efﬁcacy, disclosure of HIV status, and depression in a group of
Danish HIV-infected individuals. In particular, this study sought to
examine whether higher levels of coping self-efﬁcacy are associated
with self-disclosure and with lower levels of depression.
2. Methods
2.1. Study design and participants
This cross-sectional study investigated the relationship between
coping self-efﬁcacy, disclosure of HIV status, and depression. From
May to September 2008, a total of 503 individuals infected with HIV
were followed at the Department of Infectious Diseases of Aarhus
University Hospital and at Odense University Hospital. These two
hospitals provide for approximately 25% of the total HIV-infected
population in Denmark.For inclusion, participants had to be diagnosed with HIV
infection, be 18 years of age or older, and be able to read and write
in Danish in order to be able to complete the coping self-efﬁcacy
scale, disclosure, and HIV-related stress measurements and the
Beck Depression Inventory II correctly. Participants who could not
read or write Danish (n = 54) were excluded. A total of 449
participants were enrolled in the study.
A packet was mailed to each participant that included
information about the study, a self-report questionnaire, and a
prepaid response envelope. The following information was
collected: gender, age, educational level, ethnicity, current job,
route of HIV infection (i.e., sexual, drug use, transfusion), HIV
exposure group (i.e., homosexual, heterosexual, bisexual), depres-
sion, coping self-efﬁcacy, disclosure, and HIV-related stress. The
development of the questionnaire has been described previous-
ly.15,16
Of the 449 participants who were eligible for the study, 350
(70%) responded to the questionnaire; 304 completed the Beck
Depression Inventory II (BDI) questionnaire,26 the Coping Self-
Efﬁcacy Scale (CSE),27 and the HIV disclosure questions correctly.
The reasons for not responding included not wanting to participate
(n = 46) and no speciﬁc reason (n = 53). A total of 304 individuals
were included in the study analysis.
All participants gave written informed consent before partici-
pation. The study was approved by the Aarhus Health Human
Research Ethics Committee and by the Danish Data Protection
Agency.
2.2. Measurement of depression
The BDI26 was used to assess the prevalence and severity of
depressive symptoms. The BDI has high validity and reliability in
measuring depressive symptoms and has acceptable test–retest
reliability (r = 0.79) in a non-clinical population.
A Danish version of the BDI has been validated and used in a
Danish setting.27 Respondents were required to rate 21 items from
0 to 3 according to how they had felt during the preceding 2 weeks.
Each question has a set of at least four possible answer choices,
ranging in intensity; for example: (0) I do not feel sad, (1) I feel sad,
(2) I am sad all the time and I can’t snap out of it, (3) I am so sad or
unhappy that I can’t stand it. The BDI focuses on both the
cognitive–affective symptoms of depression, e.g., pessimism and
diminished self-esteem, and on the somatic symptoms of
depression, e.g., weight loss. A BDI score 14 is widely accepted
as an indication of depression. In this study, the score categories
were as follows: 0–13, minimal depression; 14–19, mild depres-
sion; 20–28, moderate depression; 29–63, major depression.
2.3. Coping Self-Efﬁcacy Scale (CSE) measurement
The CSE28 provides a means of measuring adaptive or positive
coping. This measure focuses on a person’s conﬁdence in his or her
ability to cope effectively, which, according to self-efﬁcacy theory,
is an important prerequisite for changing coping behavior. Higher
scores on the CSE are associated with lower levels of perceived
stress21 and with a lower likelihood of relying on a maladaptive
form of coping, especially cognitive escape/avoidance.4 The CSE
assesses a person’s conﬁdence with respect to carrying out various
effective coping behaviors, such as seeking social support and
ﬁnding solutions to problems, so that the CSE score reﬂects the
individual’s conﬁdence regarding his or her ability to effectively
cope with or manage problems. CSE is not concerned with the
methods one uses to cope, but instead focuses on the perceived
capability to engage in behaviors essential to various forms of
adaptive coping. CSE was assessed using a 26-item measure of
perceived self-efﬁcacy for coping with challenges and threats.
Table 1
Prevalence of depressive symptoms in 304 HIV- infected individuals
Becks Depression Scale II n %
Minimal depression (0–13) 204 67
Mild depression (14–19) 29 10
Moderate depression (20–28) 39 13
Major depression (29–63) 32 10
Table 2








n % n %
Gender
Male 227 67 45 20
Female 77 33 26 34
Age, years
18–29 37 12 4 11
30–44 117 39 23 20
45–59 126 41 37 29
60+ 24 8 7 29
Ethnicity
Caucasian 244 80 47 19





89 30 27 30
Primary or elementary
school >9 years
215 70 44 20
Further education
A few years of higher education
(1/2 year–2 years)
57 19 14 25
More years of higher education
(3–4 years)
144 47 23 17
Completed or almost completed
higher education (more than
4 years)
36 12 8 22
No education after secondary
school
41 14 14 34
Other 26 9 11 42
Employment
Employed 148 49 22 15
Receiving unemployment beneﬁts 5 2 2 40
Receiving rehabilitation, social
security, sickness or disability
support pension
42 14 15 36
Receiving incapacity beneﬁts 83 27 25 30
Other 26 9 7 27
Route of infection
Sexual 248 81 59 24
Blood transfusion 8 3 1 13
Injection drug use 3 1 1 33
Unknown 45 15 10 22
HIV exposure group
Homosexual 125 41 23 18
Heterosexual 149 49 37 25
Bisexual 18 6 7 38
Unknown 12 4 4 33
a BDI scores: 0–13, minimal depression; 14–19, mild depression; 20–28,
moderate depression; 29–63, major depression.
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when you’re having problems, how conﬁdent or certain are you
that you can do the following?’’ They were then asked to use an 11-
point scale to rate the extent to which they believe they could
perform behaviors important to adaptive coping, such as ‘sort out
what can be changed and what cannot be changed,’ ‘break an
upsetting problem down into smaller parts,’ ‘look for something
good in a negative situation,’ and ‘get emotional support from
friends and family.’ Anchor points on the scale were 0, ‘cannot do at
all’; 5, ‘moderately certain can do’; and 10, ‘certain can do’.
The CSE was forward- and back-translated from the original
language, US English, to Danish. The translation from US English
into Danish was performed by a person whose native language is
Danish, and a second person whose ﬁrst language is US English
performed the back-translation. After the back-translation, the
original and back-translated instruments were compared. Points of
divergence were noted and discussed with the HIV team
(physicians and nurses in the outpatient clinics), and the Danish
version was pilot-tested on 12 individuals infected with HIV. The
translation was then corrected to more accurately reﬂect
the intended meaning in the original language. The responses
from the pilot test were analyzed for content validity by analyzing
if the responses to similar items were consistent and by interviews
with participants to see if the items were clear. The ﬁnal
questionnaire was validated in a pilot study with 15 individuals
infected with HIV (face validity).
2.4. Disclosure and HIV-related stress measurements
Disclosure of HIV status was measured on a three-point scale:
(1) living openly (being open about their HIV status, disclosing
their status to others), (2) living partly openly (disclosing their
status to more than two people), and (3) living secretly (being
closed about their status, disclosing to two people or fewer). The
HIV-related stress measure assessed stress that was related to
living with HIV infection on a daily basis and was measured using
the answers ‘not at all,’ ‘a little,’ ‘somewhat,’ or ‘a lot.’
A previous study of Danish individuals infected with HIV found
that feelings that inﬂuenced their daily life with HIV, such as ‘guilt,’
shame,’ ‘anxiety,’ ‘concerns,’ ‘stress,’ ‘loneliness,’ ‘HIV inﬂuences
my whole life,’ ‘constant thoughts about HIV,’ ‘living a double-life
with HIV as a secret,’ ‘HIV limits my way of living,’ and
‘stigmatization,’ were signiﬁcantly associated with higher levels
of depression.6,15
2.5. Statistical analysis
The statistical analyses were performed with Stata 10
(StataCorp, College Station, TX, USA). All data were double-
entered. The primary variable of interest was the depression score,
which was based on the BDI. Depression was analyzed as an
absolute risk score and as a continuous risk score. We used the
Spearman’s rank correlation coefﬁcient to determine the relation-
ship between coping and depression. The test for trend was used
for the relationship between HIV status disclosure and depression.
The Kruskal–Wallis test was used to test for a relationship between
coping and disclosure. We used adjusted (multiple) logistic
regression models to determine the relationship between HIV
stress and disclosure. Statistical signiﬁcance was deﬁned as
p < 0.05.
3. Results
The characteristics of the 304 HIV-infected individuals in this
study showed that they were representative of the larger Danish
HIV-infected population (n = 3968 total) in terms of gender, age,route of infection, and HIV exposure. The study population was
also comparable to the Danish HIV-infected population regarding
baseline characteristics of the disease.29 There were symptoms of
depression (BDI >14) in 100 individuals (33%), and symptoms of
moderate/major depression (BDI  20) in 71 (23%) individuals
(Table 1). The demographic characteristics and depression scores
are presented in Table 2. The majority were in the 30–44 years age
group (39%) or the 45–59 years age group (41%), and most had a
Figure 2. Disclosure of HIV status and risk of depression in 304 Danish HIV-infected
individuals.
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equal distribution of homosexual and heterosexual orientations
(41% vs. 49%). Symptoms of depression were more pronounced in
women and in individuals who identiﬁed themselves as being
ethnicities other than Caucasian. There was a higher risk of
depression among individuals who had <9 years of primary or
elementary schooling, no further education, who received
unemployment beneﬁts, or who were undergoing rehabilitation
or received sickness or disability beneﬁts (Table 2).
Adjusted analysis among demographic factors in Table 2
showed that participants in the age group 45–59 years (odds
ratio (OR) 3.4, 95% conﬁdence interval (CI) 1.1–10.4; p = 0.029),
women (OR 2.6, 95% CI 1.2–3.7; p = 0.013), those of ethnicities
other than Caucasian (OR 0.34, 95% CI 0.19–0.63; p = 0.001), those
with <9 years of primary or elementary schooling (OR 1.8, 95% CI
1.02–3.2; p = 0.04), those undergoing rehabilitation (OR 3.2, 95% CI
1.5–6.9; p = 0.003), and those in receipt of sickness or disability
beneﬁts (OR 2.4, 95% CI 1.3–4.7; p = 0.007) had a higher risk of
depression.
There was a signiﬁcant inverse relationship between lower
coping self-efﬁcacy and a higher depression score (Spearman’s rho
= 0.71; the test of H0: BDI and coping, probability > t = 0.0001;
Figure 1).
A test for trend was performed to examine if there was an
association between disclosure and depression. Individuals who
reported that they lived secretly/disclosed their HIV status to fewer
than two people, had signiﬁcantly higher depression scores (OR
4.1, 95% CI 1.6–10.3; p = 0.002) than those who lived openly
(i.e., disclosed their status to others). Those who lived partly openly
(disclosing their HIV status to more than two people) were more
likely to be at risk of depression than those who were living openly
(OR 2.4, 95% CI 1.4–5.8; p = 0.04) (Figure 2). The Kruskal–Wallis
test showed a signiﬁcant association between higher coping self-
efﬁcacy and living openly with HIV status versus living secretly/
partly openly (p < 0.02).
Multivariate logistic regression, after adjusting for the three
different disclosure strategies and the association with HIV-related
stress, showed a signiﬁcant association between HIV-related stress
and participants who lived secretly compared to either living
openly (OR 3.3, 95% CI 1.6–6.8; p < 0.001) or living partly openly
(OR 2.5, 95% CI 1.2–3.7; p < 0.012).
4. Discussion
We found a signiﬁcant relationship between the degree of
coping self-efﬁcacy and depression in HIV-infected individuals in a
Danish setting. Non-disclosure of HIV status was signiﬁcantly
associated with depression. There was a signiﬁcant relationshipFigure 1. Risk of depression and conﬁdence in performing coping behaviors in 304
Danish HIV-infected individuals.between having a higher degree of coping self-efﬁcacy and living
openly with HIV versus living secretly/partly openly. Other studies
have found that for people coping with stressors associated with
living with HIV, avoidance and disengagement coping styles are
related to increased anxiety and depression,30,31 while decreases in
avoidance coping following interventions are related to decreased
depression and grief.32,33
The objective of this study was not to identify speciﬁc coping
behaviors, but it could be argued that individuals with high coping
self-efﬁcacy are likely to be more resourceful and seek coping
resources and learning strategies to solve problems, thereby
reducing their risk of depression. Coping self-efﬁcacy is not
concerned with the methods one uses to cope but rather with the
perceived capability of managing the situation. Both disclosing and
not disclosing one’s HIV status can serve as a way of coping with
being infected with HIV. However, not disclosing one’s status may
be more associated with the maladaptive form of coping, cognitive
escape/avoidance. These ﬁndings suggest that rather than avoiding
disclosure, interventions directed at increasing self-efﬁcacy to
determine how to disclose or to seek help in doing so from others
may be particularly helpful in reducing the risk of depression.
There are a number of approaches to HIV disclosure, and no single
approach is optimal for relieving depression.17,34 These ﬁndings
suggest that HIV-infected individuals who are low in coping self-
efﬁcacy lack adaptive coping skills to handle disclosure. They
cannot solve the problems of how to disclose their HIV status and
to whom they should disclose it. Avoiding disclosure leads to
isolation, increasing the risk of depression. Interventions such as
coping effectiveness training that teach coping skills for handling
HIV-related stressors such as disclosure may be particularly
helpful in reducing the risk of depression. A review by Moskowitz
et al.35 about coping with HIV-related issues notes that it is
important to measure situation-speciﬁc forms of coping. Context-
speciﬁc coping strategies that are particularly effective can be
translated directly into programs that are designed to help people
cope with HIV, whereas ﬁndings about general coping are less
applicable. Interventions such as coping effectiveness training
provide this type of situation-speciﬁc coping support and
training.21
A review by Harding et al.36 suggests that greater understand-
ing of how various subgroups cope with HIV (e.g., subgroups based
on age, gender, ethnicity, or personality disorders) will lead to
improved interventions that will enhance health, potentially
prolonging and improving the quality of life. Our study revealed
that there was a higher risk of depression in women, in individuals
with an ethnicity other than Caucasian, and in those with <9 years
of primary or elementary schooling, those with no further
education, individuals in receipt of unemployment beneﬁts, those
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disability beneﬁts. This is in agreement with previous studies.37
These factors might also inﬂuence disclosure of HIV, risk of
depression, and the degree of coping self-efﬁcacy.
Personality types also inﬂuence a person’s ability to cope. A
meta-analysis by Chida and Vedhara38 showed that personality
types or coping styles and psychological stress were more strongly
associated with greater HIV disease progression than stress stimuli
per se. This is consistent with evidence that our perceptions of and
responses to stressors, rather than the stressors themselves,
predict vulnerability to stress-related diseases among people with
similar life experiences.39 Furthermore, many people infected with
HIV struggle with co-morbidities that are associated with poorer
self-reported health status and quality of life.36
Cognitive behavioral interventions such as coping effectiveness
training,21 as well as stress and coping therapy,19 strive to increase
coping effectiveness with regard to problem-solving and other
forms of adaptive coping in order to reduce psychological stress,
improve well-being, and increase positive psychological states. If
the goal is to provide training in coping skills, it is also essential
that individuals develop the sense that they can perform such skills
and that doing so will reduce their stress.20,21 The CSE provides a
standardized measurement of coping self-efﬁcacy, but there is no
current standardized measurement of coping strategies that apply
to people infected with HIV. Further work is urgently needed to
generate items that assess coping strategies in this population and
that can be validated for further outcome research.36
Healthcare workers should be aware of the variety of ways in
which the ability to disclose HIV status ﬁts into the overall process
of adjustment to living with HIV.17 Should we consider going
beyond the general measures of coping and consider including
types of coping that are more HIV-speciﬁc, such as coping with the
disclosure of HIV status, which is a lifelong stressor? For example,
disclosure of one’s HIV status to friends, family, and sexual
partners is a stressor for many living with HIV, but not disclosing it
is a risk and may involve types of coping that are not captured by
the standard coping scales.
The present study has some limitations. The questionnaire was in
Danish, limiting participation to people infected with HIV who were
literate in Danish. The participants were not representative in terms
of injection drug use; only a few injection drug users participated in
this study as the majority are followed at the departments of
infectious diseases in Copenhagen. This study sample is, however,
representative of the total Danish HIV population outside the capital
of Denmark. The cross-sectional design of the study does not show
how coping strategies vary over time, and we cannot deduce causal
pathways. There might be gender and cultural differences,
differences according to the route of infection (i.e., infection via
homosexual, heterosexual, or transsexual contact, or from drug use,
or from contracting HIV at birth), co-morbidities, age, or differences
in children, youths, and adults that we did not consider.
Approximately 10% of adults in the general population have
personality disorders, but the prevalence rates of personality
disorders are higher in the HIV-infected population (19–36%).40
We do not have information about this prevalence in this study
population, which might have biased our results. Speciﬁcally,
personality disorders could lead to underestimation or overestima-
tion of a person’s conﬁdence in his or her ability to cope effectively.
Future research should continue to explore the relationship
between depression and coping skills in a larger random sample
and in a more diverse HIV-infected population. We also suggest
that future research should examine disclosure and interventions
designed to increase comfort with disclosure. There is a need for
early psychological interventions for those who are newly-
diagnosed with HIV to achieve better psychological status. People
infected with HIV are now living for extended periods of time, somore attention should be devoted to the speciﬁc medical and
psychosocial needs of this aging population.41 Future studies
should examine the use and effectiveness of speciﬁc and general
coping strategies in regard to both speciﬁc stressors, such as
disclosure, and to general stressors, such as chronic illness,
comorbidities, and personality types. The relationship of coping
strategies to physical and mental health outcomes also needs to be
further examined.42
Our ﬁndings highlight the need for research that explores the
association between the coping strategies of those infected with
HIV and depression in order to develop effective interventions that
increase coping strategies and that have long-term effectiveness.
The CSE scale provides an alternate approach to the measurement
of coping for intervention studies.27
We conclude that individuals who have low levels of coping
self-efﬁcacy are more likely to report living secretly with HIV and
to be depressed. Disclosing HIV may constitute a social stressor,
and a lack of coping self-efﬁcacy may increase the likelihood of
non-disclosure as well as depression. Interventions that enhance
self-efﬁcacy may increase one’s ability to manage the daily
demands of living with HIV, increasing disclosure and reducing
depression.
Health professionals need innovative strategies and tools to
better understand and improve physical and mental health
outcomes for people infected with HIV. Teaching adaptive coping
skills to deal with disclosure and providing opportunities for
practice to increase self-efﬁcacy may help prevent or reduce the
risk of depression. There is a need to develop holistic interventions
that address these multiple challenges.
Acknowledgements
This project was funded by Aarhus University Hospital, the
Skejby Research Foundation, the Health Insurance Foundation, the
Central Denmark Region Health Research Foundation, and the
Lundbeck Foundation. The authors are grateful to the participants,
without whom this work would not have been possible.
Conﬂict of interest: None declared.
References
1. Leserman J. Role of depression, stress, and trauma in HIV disease progression.
Psychosom Med 2008;70:539–45.
2. Rabkin JG. HIV and depression: review and update. Curr HIV/AIDS Rep
2008;5:163–71.
3. Leserman J, Petitto JM, Gu H, Gaynes BN, Barroso J, Golden RN, et al. Progression
to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological
predictors. Psychol Med 2002;32:1059–73.
4. Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders
in HIV-positive patients: epidemiology and impact on antiretroviral therapy.
Drugs 2006;66:769–89.
5. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncom-
pliance with medical treatment: meta-analysis of the effects of anxiety and
depression on patient adherence. Arch Intern Med 2000;160:2101–7.
6. Rodkjaer L, Laursen T, Christensen NB, Lomborg K, Ostergaard L, Sodemann M.
Changes in depression in a cohort of Danish HIV-positive individuals: time for
routine screening. Sex Health 2011;8:214–21.
7. Alciati A, Gallo L, Monforte AD, Brambilla F, Mellado C. Major depression-related
immunological changes and combination antiretroviral therapy in HIV-sero-
positive patients. Hum Psychopharmacol 2007;22:33–40.
8. Bouhnik AD, Pre´au M, Vincent E, Carrieri MP, Gallais H, Lepeu G, et al. Depres-
sion and clinical progression in HIV-infected drug users treated with highly
active antiretroviral therapy. Antivir Ther 2005;10:53–61.
9. Pence BW, Miller WC, Gaynes BN, Eron Jr JJ. Psychiatric illness and virologic
response in patients initiating highly active antiretroviral therapy. J Acquir
Immune Deﬁc Syndr 2007;44:159–66.
10. Cruess DG, Evans DL, Repetto MJ, Gettes D, Douglas SD, Petitto JM. Prevalence,
diagnosis, and pharmacological treatment of mood disorders in HIV disease.
Biol Psychiatry 2003;54:307–16.
11. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ,
et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-
seropositive women: longitudinal analysis from the HIV Epidemiology Re-
search Study. JAMA 2001;285:1466–74.
L. Rodkjaer et al. / International Journal of Infectious Diseases 22 (2014) 67–727212. Leserman J. HIV disease progression: depression, stress, and possible mecha-
nisms. Biol Psychiatry 2003;54:295–306.
13. Lima VD, Geller J, Bangsberg DR, Patterson TL, Daniel M, Kerr T, et al. The effect
of adherence on the association between depressive symptoms and mortality
among HIV-infected individuals ﬁrst initiating HAART. AIDS 2007;21:1175–83.
14. Rodkjaer L, Laursen T, Balle N, Sodemann M. Depression in HIV patients is
under-diagnosed: a cross-sectional study among HIV patients in Denmark. HIV
Med 2010;11:46–53.
15. Berg CJ, Michelson SE, Safren SA. Behavioral aspects of HIV care: adherence,
depression, substance use, and HIV-transmission behaviours. Infect Dis Clin
North Am 2007;21:181–200.
16. Holt R, Court P, Vedhara K, Nott KH, Holmes J, Snow MH. The role of disclosure in
coping with HIV infection. AIDS Care 1998;10:49–60.
17. Rodkjaer L, Sodemann M, Ostergaard L, Lomborg K. Disclosure decisions: HIV-
positive persons coping with disease-related stressors. Qual Health Res
2011;21:1249–59.
18. Marshall GD. The adverse effects of psychological stress on immunoregulatory
balance: applications to human inﬂammatory diseases. Immunol Allergy Clin
North Am 2011;31:133–40.
19. Lazarus RS, Folkman S. Stress, appraisal, and coping. New York: Springer; 1984.
20. Bandura A. Self-efﬁcacy: toward a unifying theory of behavior change. Psychol
Rev 1977;84:191–215.
21. Chesney MA, Chambers DB, Taylor JM, Johnson LM, Folkman S. Coping effec-
tiveness training for men living with HIV: results from a randomized clinical
trial testing a group-based intervention. Psychosom Med 2003;65:1038–46.
22. Ashton E, Vosvick M, Chesney M, Gore-Felton C, Koopman C, O’Shea K, et al.
Social support and maladaptive coping as predictors of the change in physical
health symptoms among persons living with HIV/AIDS. AIDS Patient Care STDs
2005;19:587–98.
23. Strentz T, Auerbach SM. Adjustment to the stress of simulated captivity: effects
of emotion-focused versus problem-focused preparation on hostages differing
in locus of control. J Pers Soc Psychol 1998;5:652–60.
24. Vitaliano PP, DeWolfe DJ, Maiuro RD, Russo J, Katon W. Appraised changeability
of a stressor as a modiﬁer of the relationship between coping and depression: a
test of the hypothesis of ﬁt. J Pers Soc Psychol 1990;59:582–92.
25. Vosvick M, Gore-Felton C, Koopman C, Thoresen C, Krumboltz J, Spiegel D.
Maladaptive coping strategies in relation to quality of life among HIV/AIDS
adults. AIDS Behav 2002;6:97–106.
26. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring
depression. Arch Gen Psychiatry 1961;4:561–71.
27. Uher R, Farmer A, Maier W, Rietschel M, Hauser J, Marusic A, et al. Measuring
depression: comparison and integration of three scales in the GENDEP study.
Psychol Med 2008;38:289–300.28. Chesney MA, Neilands TB, Chambers DB, Taylor JM, Folkman S. A validity and
reliability study of the coping self-efﬁcacy scale. Br J Health Psychol
2006;11:421–37.
29. Obel N, Engsig FN, Rasmussen LD, Larsen MV, Omland LH, Sørensen HT. Cohort
proﬁle: The Danish HIV Cohort Study. Int J Epidemiol 2009;38:1202–6.
30. Gonzalez JS, Penedo FJ, Antoni MH, Duran RE, McPherson-Baker S, Ironson G,
et al. Social support, positive states of mind, and HIV treatment adherence in
men and women living with HIV/AIDS. Health Psychol 2004;23:413–8.
31. Gore-Felton C, Koopman C, Spiegel D, Vosvick M, Brondino M, Winningham A.
Effects of quality of life and coping on depression among adults living with HIV/
AIDS. J Health Psychol 2006;11:711–29.
32. Hansen NB, Tarakeshwar N, Ghebremichael M, Zhang H, Kochman A, Sikkema
KJ. Longitudinal effects of coping on outcome in a randomized controlled trial of
a coping group intervention for HIV-positive adults with AIDS-related bereave-
ment. Death Stud 2006;30:609–36.
33. Smith NG, Tarakeshwar N, Hansen NB, Kochman A, Sikkema KJ. Coping med-
iates outcome following a randomized group intervention for HIV-positive
bereaved individuals. J Clin Psychol 2009;65:319–35.
34. Hult JR, Wrubel J, Bra¨nstro¨m R, Acree M, Moskowitz JT. Disclosure and nondis-
closure among people newly diagnosed with HIV: an analysis from a stress and
coping perspective. AIDS Patient Care STDS 2012;26:181–90.
35. Moskowitz JT, Hult JR, Bussolari C, Acree M. What works in coping with HIV? A
meta-analysis with implications for coping with serious illness. Psychol Bull
2009;135:121–41.
36. Harding R, Clucas C, Lampe FC, Date HL, Fisher M, Johnson M, et al. What factors
are associated with patient self-reported health status among HIV outpatients?
A multi-centre UK study of biomedical and psychosocial factors. AIDS Care
2012;24:963–71.
37. Blalock AC, McDaniel JS, Farber EW. Effect of employment on quality of life and
psychological functioning in patients with HIV/AIDS. Psychosomatics
2002;43:400–4.
38. Chida Y, Vedhara K. Adverse psychosocial factors predict poorer prognosis in
HIV disease: a meta-analytic review of prospective investigations. Brain Behav
Immun 2009;23:434–45.
39. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med
1998;338:171–9.
40. Treisman GJ, Angelino AF. The psychiatry of AIDS. A guide to diagnosis and
treatment. Baltimore, MD: The Johns Hopkins University Press; 2004.
41. Justice A. HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep
2010;7:69–76.
42. Di Benedetto M, Lindner H, Aucote H, Churcher J, McKenzie S, Croning N, et al.
Co-morbid depression and chronic illness related to coping and physical and
mental health status. Psychol Health Med 2013 Jun 3. [Epub ahead of print].
